Skip to main content
IDEAYA Biosciences, Inc. logo

IDEAYA Biosciences, Inc. — Investor Relations & Filings

Ticker · IDYA ISIN · US45166A1025 LEI · 549300ULW08F62IJML11 US Manufacturing
Open in API
Filings indexed 466 across all filing types
Latest filing 2020-04-23 Major Shareholding Noti…
Country US United States of America
Listing US IDYA

About IDEAYA Biosciences, Inc.

https://www.ideayabio.com/

IDEAYA Biosciences, Inc. is a clinical-stage precision medicine oncology company focused on the discovery, development, and commercialization of targeted therapeutics for cancer. The company's primary scientific approach is synthetic lethality, an emerging class of precision medicine that targets cancer cells based on specific genetic alterations. IDEAYA develops potential first-in-class and best-in-class therapies for patient populations selected using molecular diagnostics. Its integrated platform combines capabilities in target and biomarker discovery with the development of small molecule and protein degrader therapeutics to address unmet needs in cancer treatment.

Recent filings

Filing Released Lang Actions
SC 13G
Major Shareholding Notification
2020-04-23 English
FORM 4
Director's Dealing
2020-04-16 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K Current Report filed with the SEC, which is used to announce major events that shareholders should know about. The content specifically details the departure of a senior officer (Senior Vice President and Chief Medical Officer) and related agreements. This fits the category of announcements about changes in the company's board of directors or senior management. The document is not a full financial report, earnings release, or other report type, but rather a management change announcement. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is 4202 characters, which is consistent with a typical 8-K filing for management changes, not a full report or announcement of a report publication.
2020-04-07 English
FORM 4
Director's Dealing
2020-04-01 English
S-8_MARCH_2020
Capital/Financing Update Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC by IDEAYA Biosciences, Inc. It relates to the registration of securities under employee benefit plans (2019 Incentive Award Plan and 2019 Employee Stock Purchase Plan). The document includes details about the securities to be registered, calculation of registration fees, incorporation by reference of prior filings, and signatures of company officers. Form S-8 is specifically used for registering securities to be offered to employees under stock plans and is not a financial report, earnings release, or management discussion. It is a capital/financing related filing concerning securities registration. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is the actual registration statement, not just an announcement or a certification, so it is not RPA or RNS. Confidence is high due to clear identification of Form S-8 and related securities registration content.
2020-03-24 English
10-K
Annual Report FY 2019
2020-03-24 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.